AS
Andrew John Hugh MacIntyre Sims
Chief Financial Officer

Andrew John Hugh MacIntyre Sims insider trades: Plus Therapeutics (PSTV) stock purchases

Chief Financial Officer, Plus Therapeutics Last trade Nov 4, 2025 21 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
8
Open-market trades
since 2021
2
Companies
last trade 2025

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Andrew reports to the SEC

Open-market buys and sales

8 trades reported on SEC Form 4, newest first

DateStockTypeValue
Nov 4, 2025PSTV↑ Buy$10K
Sep 10, 2024PSTV↑ Buy$5K
May 8, 2024PSTV↑ Buy$10K
Apr 26, 2022PSTV↑ Buy$2K
Mar 1, 2022PSTV↑ Buy$2K
Nov 2, 2021PSTV↑ Buy$2K
Oct 26, 2021PSTV↑ Buy$3K
Jul 28, 2021PSTV↑ Buy$8K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Andrew John Hugh MacIntyre Sims's insider trades

Andrew John Hugh MacIntyre Sims is Chief Financial Officer at Plus Therapeutics (PSTV). Since Jul 28, 2021, Andrew has reported 8 open-market purchases worth $43K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (9 filings), option exercises (5 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PSTV insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.